Geriatric Assessment and Promotores (GAP) Pilot Feasibility Study

Sponsor
University of California, Davis (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06125145
Collaborator
(none)
49
1
1
17.9
2.7

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to test a new way to help older adults who have had cancer.

The researchers want to see if a program that assesses participants health and aging is achievable and makes a difference. A community health worker/promotora de salud will assess their health and provide coaching to help them feel better. This is important because older adults with cancer often have other health issues that are not addressed after completing treatment. The researchers want to make sure they get the care they need.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Geriatric Assessment and Promotora Coaching
N/A

Detailed Description

The proposed study is a single arm feasibility study of a supportive care intervention. Phase is not applicable because this is not a drug trial. The study involves enrolling older adult non-metastatic cancer survivors between 1 month and 24 months after the completion of any definitive (e.g., curative intent) cancer treatment. The objective is to determine if a Community Health Worker (CHW)-led geriatric assessment and coaching intervention to assess geriatric syndromes is a feasible modality in community-dwelling older adult cancer survivors. The tailored assessment intervention (geriatric assessment and coaching) is hypothesized to potentially be a feasible process to monitor patients that would otherwise not access geriatric services after completing cancer treatment. Coping and social support are hypothesized mediators to the relationship between physical function and health outcomes (e.g., physical function, mental health), influenced by sociodemographic contextual factors. Implementation science concepts, such as acceptability and scalability will also be collected. The study CHW will perform the geriatric assessment and coaching components with each of the patients in the study. The assessment component of the bundle intervention involves screening for frailty and cognition, occurring prior to the coaching session. The CHW will conduct a more thorough geriatric assessment for polypharmacy, depression, symptom burden, and social support. In follow up visits after the geriatric assessment the CHW will deliver the coaching component (derived from the Problem Solving Coaching Model) to participants. Each of the intervention sessions will consist of 45-minute appointments with tailored feedback of the geriatric assessment domains, caregiver and family support, and navigation to additional palliative care resources at the study institution. The researchers developed the content in the tailored assessment intervention from preliminary work and thorough review of scientific literature.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
49 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
TAILORED GERIATRIC ASSESSMENT AND PROMOTORES PILOT FEASIBILITY STUDY
Anticipated Study Start Date :
Feb 7, 2024
Anticipated Primary Completion Date :
Feb 6, 2025
Anticipated Study Completion Date :
Aug 6, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Feasibility Arm

All enrolled participants will receive the pilot Geriatric Assessment and Promotora Coaching intervention.

Behavioral: Geriatric Assessment and Promotora Coaching
In Visit 1 the community health worker/promotora will assess frailty, cognition, polypharmacy, depression, symptom burden, and social support. In Visits 2 and 3 the community health worker will deliver interpersonal communication techniques to deliver the problem solving coaching format, leverage cultural congruence with clients, and provide social support to assist in adopting healthy behaviors.

Outcome Measures

Primary Outcome Measures

  1. Describe the percentage of participants that complete 2 out of 3 study visits [6 month]

    Calculate percentage of participants that complete study compared to total enrolled (Goal: 65)

Secondary Outcome Measures

  1. Describe physical function throughout the study period [Baseline to 6 month]

    PROMIS physical function

  2. Describe mental health outcomes [Baseline to 6 month]

    PROMIS: Depression, Anxiety, and Fatigue

  3. Describe self-efficacy [Baseline to 6 month]

    PROMIS Self Efficacy

  4. Describe perceived social support [Baseline to 6 month]

    PROMIS Emotional Support

  5. Describe quality of life [Baseline to 6 month]

    Quality of Life Questionnaire in the Elderly (ELD-14)

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Age 65-90

  2. Able to understand study procedures and to comply with them for the entire length of the study.

  3. Diagnosis of Stage II-III breast, colorectal, or prostate cancer in within 1 to 24 months.

  4. Completed course of definitive therapy within 12 months from enrollment into the study.

  5. Proficient in English or Spanish

  6. Reside within the UC Davis Health catchment area.

  7. Has self-reported primary caregiver aged 21-90 years.

Exclusion Criteria:
  1. Contraindication to any study-related procedure or assessment.

  2. Patient is unable to independently deliver informed consent.

  3. Patient screens positive for cognitive impairment (6CIT > 8)

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of California, Davis Sacramento California United States 95817

Sponsors and Collaborators

  • University of California, Davis

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of California, Davis
ClinicalTrials.gov Identifier:
NCT06125145
Other Study ID Numbers:
  • CCSN014
First Posted:
Nov 9, 2023
Last Update Posted:
Nov 9, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of California, Davis
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 9, 2023